Oceania · General news · The Courier-Mail
Health Check: Clarity shares soar on ‘breakthrough’ FDA designation
Detailed summary
Shares in radiopharma developer Clarity Pharmaceuticals (ASX:CU6) today soared more than 30% after the US Food & Drug Administration (FDA) granted ‘breakthrough’ designation to…
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.couriermail.com.au)
